Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CapsoVision (CV) Accumulated Expenses (2024 - 2025)

CapsoVision's Accumulated Expenses history spans 2 years, with the latest figure at $2.7 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 373.99% to $2.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 million, a 373.99% increase, with the full-year FY2025 number at $2.7 million, up 373.99% from a year prior.
  • Accumulated Expenses hit $2.7 million in Q4 2025 for CapsoVision, down from $2.8 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CV hit a ceiling of $2.8 million in Q3 2025 and a floor of $569000.0 in Q4 2024.